Haemonetics | HAE - Ebitda

Stock Price
59.92
Daily Change
0.43 0.72%
Monthly
2.27%
Yearly
-8.55%
Q1 Forecast
58.11

Haemonetics reported $115.53M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Avanos Medical USD 10M 73.9M Sep/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
ICU Medical USD 98.19M 27.67M Dec/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
Masimo USD 91.9M 19.9M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Neogen USD 48.75M 13.28M Sep/2025
OraSure Technologies USD 920K 9.87M Jun/2024
Quidel USD 153.3M 23.8M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Steris USD 389.7M 22.5M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Surmodics USD 1.53M 485K Sep/2024
Teleflex USD -328.81M 536.43M Sep/2025
Terumo JPY 69.99B 3.22B Dec/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
US Physical Therapy USD 24.75M 899K Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025